Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5866 posts found.

Eric Abadie resigns as chair of the CHMP

April 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Eric Abadie

Dr Eric Abadie has told the European Medicines Agency that he is resigning as chair of the Committee for Medicinal …
Appointment

Drugmakers ‘premature’ in requests for metal impurity data

April 5, 2012 Manufacturing and Production ICH, manufacturing, metal impurity

Pharmaceutical manufacturers are acting ‘prematurely’ when asking excipient suppliers to provide metal impurity levels, according to a new position paper …
News
Lonza picture

Lonza names Ridinger as new chief executive

April 5, 2012 Manufacturing and Production Cognis, Lonza, Ridinger

Swiss contract manufacturer and ingredients supplier Lonza has appointed Richard Ridinger as its new chief executive, replacing Stefan Borgas who …
News

Orphan Medicinal Products in the EU- Free Webinar

April 4, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Orphan Medicinal Products in the EU: Eligibility, Orphan Designation and IncentivesThe structure of this webinar is:Introduction: Legislative Basis and Criteria …
News
Press release

EMG appoints two new senior members

April 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB

A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG).   EMG is the voice of …
Appointment

Glyn Edwards appointed as chief executive of Summit

April 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Glyn Edwards, summit

Summit, a UK drug discovery company, has appointed Glyn Edwards as its new chief executive. Edwards will take up the …
Appointment

New Europe-wide approach for the classification of commercially confidential information and personal data in MAAs

April 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Heads of Medicines Agencies(HMA) and the European Medicines Agency (EMA) have adopted a joint guidance document, providing a consistent …
News
Press release

Novasep expands in China, raises €40m for investments

April 3, 2012 Manufacturing and Production China, Novasep, Shanghai, manufacturing

French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …
News

Pharma manufacturing news in brief

April 3, 2012 Manufacturing and Production Gerresheimer and Foster Wheeler, Pharmax, Sigma-Aldrich

Pharmax starts building Dubai plant, Brazil tightens gelatin controls, plus updates from Sigma-Aldrich, Gerresheimer and Foster Wheeler.
News

Michael Cola resigns from Shire

April 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire

Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm.  “On behalf of …
Appointment

Novartis to construct pharma plant in Turkey

April 2, 2012 Manufacturing and Production Novartis, Turkey, manufacturing

Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …
News

Piramal opens ADC plant in Scotland

April 2, 2012 Manufacturing and Production ADC, Abbott, Piramel

India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …
News
Teva image

Teva sells Canadian plant to CMO

March 30, 2012 Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing

Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …
News

Amylin dismisses BMS acquisition deal

March 30, 2012 Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly

Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …
News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …
Appointment
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026